tiprankstipranks
Trending News
More News >
Invion (AU:IVX)
ASX:IVX

Invion (IVX) Price & Analysis

Compare
3 Followers

IVX Stock Chart & Stats


---

Financials

Quarterly

IVX FAQ

What was Invion’s price range in the past 12 months?
Invion lowest share price was AU$0.10 and its highest was AU$0.43 in the past 12 months.
    What is Invion’s market cap?
    Invion’s market cap is $7.52M.
      When is Invion’s upcoming earnings report date?
      Invion’s upcoming earnings report date is Aug 29, 2025 which is in 133 days.
        How were Invion’s earnings last quarter?
        Invion released its earnings results on Feb 28, 2025. The company reported -AU$0.028 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.028.
          Is Invion overvalued?
          According to Wall Street analysts Invion’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Invion pay dividends?
            Invion does not currently pay dividends.
            What is Invion’s EPS estimate?
            Invion’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Invion have?
            Invion has 77,478,386 shares outstanding.
              What happened to Invion’s price movement after its last earnings report?
              Invion reported an EPS of -AU$0.028 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Invion?
                Currently, no hedge funds are holding shares in AU:IVX
                ---

                Invion Stock Smart Score

                Company Description

                Invion

                Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Actinogen Medical Limited
                Biotron Limited
                Imugene Limited
                Patrys Limited
                Race Oncology Ltd.
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis